GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS

Aim. Apolipoprotein E (apoE) and paraoxonase 1 (PON1) participate in regulation of blood lipoprotein levels, as well as in their hydrolysis and oxidation. We assumed that individual alleles of the apoE and PON1 genes, along with the changes in concentrations of these substances, contribute to the de...

Full description

Bibliographic Details
Main Authors: E. V. Shcheglova, A. I. Laipanova, M. K. Baikulova, Z. K. Chotchaeva, S. Sh. Rogova, V. N. Kolesnikov, O. I. Boeva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2017-11-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1064
id doaj-80a3d40c4f2f428b9961fae56c417862
record_format Article
spelling doaj-80a3d40c4f2f428b9961fae56c4178622021-07-28T14:02:30Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202017-11-0101010711210.15829/1560-4071-2017-10-107-112876GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSISE. V. Shcheglova0A. I. Laipanova1M. K. Baikulova2Z. K. Chotchaeva3S. Sh. Rogova4V. N. Kolesnikov5O. I. Boeva6Stavropol State Medical University, Ministry of Healthcare of the Russian FederationStavropol State Medical University, Ministry of Healthcare of the Russian FederationRegional Clinical Center of CardiologyStavropol State Medical University, Ministry of Healthcare of the Russian FederationStavropol State Medical University, Ministry of Healthcare of the Russian FederationRegional Clinical Center of CardiologylStavropol State Medical University, Ministry of Healthcare of the Russian FederationAim. Apolipoprotein E (apoE) and paraoxonase 1 (PON1) participate in regulation of blood lipoprotein levels, as well as in their hydrolysis and oxidation. We assumed that individual alleles of the apoE and PON1 genes, along with the changes in concentrations of these substances, contribute to the development of calcific aortic valve stenosis (CAVS).Material and methods. The study group included 108 patients with CAVS and 46 patients without any signs of the aortic valve lesions were determined. The serum apoE and PON1 levels were measured by ELISA, the Leu28Pro mutation in the apoE (rs429358) gene and the Gln192Arg mutation in the PON1 (rs662) gene were detected using PCR SNP-EXPRESS electrophoresis detection scheme.Results. Increased serum levels of apoE (0,05 vs 0,03 µg/l, p<0,001) and PON1 (4,8 vs 3,4 µg/ml, p<0,05) were detected in CAVS patients. The frequencies of allelic polymorphisms of the apoE and PON1 genes were similar in the two groups. 28Pro allele of the apoE gene was associated with increased level of low density lipoproteins in CAVS (3,9±1,05 vs 3,13±1,08 mmol/l, p<0,02) and total cholesterol in the controls (6,2; 6,5 vs 5,11±0,89 mmol/l, p<0,05). The PON1 genotype had no effect on lipid metabolism in CAVS patients. Controls with 192Gln allele demonstrated decreased blood levels of apoE (0,02 vs 0,05 µg/l, р<0,01) and increased PON1 serum concentration (4,1 vs 3,3 µg/ml, р<0,01).Conclusions. CAVS patients have increased serum levels of apoE and PON1; the apoE level is an independent predictor of aortic calcification. Polymorphic markers Gln192Arg of the PON1 gene and Leu28Pro of the apoE gene are not associated with CAVS.https://russjcardiol.elpub.ru/jour/article/view/1064apoliporotein eparaoxonase 1gene polymorphismcalcific aortic stenosis
collection DOAJ
language Russian
format Article
sources DOAJ
author E. V. Shcheglova
A. I. Laipanova
M. K. Baikulova
Z. K. Chotchaeva
S. Sh. Rogova
V. N. Kolesnikov
O. I. Boeva
spellingShingle E. V. Shcheglova
A. I. Laipanova
M. K. Baikulova
Z. K. Chotchaeva
S. Sh. Rogova
V. N. Kolesnikov
O. I. Boeva
GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
Российский кардиологический журнал
apoliporotein e
paraoxonase 1
gene polymorphism
calcific aortic stenosis
author_facet E. V. Shcheglova
A. I. Laipanova
M. K. Baikulova
Z. K. Chotchaeva
S. Sh. Rogova
V. N. Kolesnikov
O. I. Boeva
author_sort E. V. Shcheglova
title GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
title_short GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
title_full GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
title_fullStr GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
title_full_unstemmed GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
title_sort genotypes and serum levels of apolipoprotein e and paraoxonase 1 in calcific aortic valve stenosis
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2017-11-01
description Aim. Apolipoprotein E (apoE) and paraoxonase 1 (PON1) participate in regulation of blood lipoprotein levels, as well as in their hydrolysis and oxidation. We assumed that individual alleles of the apoE and PON1 genes, along with the changes in concentrations of these substances, contribute to the development of calcific aortic valve stenosis (CAVS).Material and methods. The study group included 108 patients with CAVS and 46 patients without any signs of the aortic valve lesions were determined. The serum apoE and PON1 levels were measured by ELISA, the Leu28Pro mutation in the apoE (rs429358) gene and the Gln192Arg mutation in the PON1 (rs662) gene were detected using PCR SNP-EXPRESS electrophoresis detection scheme.Results. Increased serum levels of apoE (0,05 vs 0,03 µg/l, p<0,001) and PON1 (4,8 vs 3,4 µg/ml, p<0,05) were detected in CAVS patients. The frequencies of allelic polymorphisms of the apoE and PON1 genes were similar in the two groups. 28Pro allele of the apoE gene was associated with increased level of low density lipoproteins in CAVS (3,9±1,05 vs 3,13±1,08 mmol/l, p<0,02) and total cholesterol in the controls (6,2; 6,5 vs 5,11±0,89 mmol/l, p<0,05). The PON1 genotype had no effect on lipid metabolism in CAVS patients. Controls with 192Gln allele demonstrated decreased blood levels of apoE (0,02 vs 0,05 µg/l, р<0,01) and increased PON1 serum concentration (4,1 vs 3,3 µg/ml, р<0,01).Conclusions. CAVS patients have increased serum levels of apoE and PON1; the apoE level is an independent predictor of aortic calcification. Polymorphic markers Gln192Arg of the PON1 gene and Leu28Pro of the apoE gene are not associated with CAVS.
topic apoliporotein e
paraoxonase 1
gene polymorphism
calcific aortic stenosis
url https://russjcardiol.elpub.ru/jour/article/view/1064
work_keys_str_mv AT evshcheglova genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
AT ailaipanova genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
AT mkbaikulova genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
AT zkchotchaeva genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
AT sshrogova genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
AT vnkolesnikov genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
AT oiboeva genotypesandserumlevelsofapolipoproteineandparaoxonase1incalcificaorticvalvestenosis
_version_ 1721269136463495168